The blockade of TGF-β and VEGF resulted in improved efficiency of chemotherapeutic agents in 4T1 mammary tumor model and breast cancer patients through the recruitment and normalization of extracellular matrix, particularly collagen-coated matrices [72,73]. This evidence concerns the gene TGFB1 and breast carcinoma.